Arcus Biosciences, Inc. (RCUS) Ownership

$9.12

north_east
$0.5 (5.8%)
Day's range
$8.65
Day's range
$9.35

Arcus Biosciences, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
GILEAD SCIENCES, INC. 02/13/2025 30.06 M $447.61 M   100.00% 32.89%
BLACKROCK, INC. 02/07/2025 9.69 M $144.35 M   -0.39% 10.61%
VANGUARD GROUP INC 02/11/2025 5.39 M $80.25 M   -1.45% 5.90%
FMR LLC 02/13/2025 4.05 M $60.34 M   -9.29% 4.43%
WOODLINE PARTNERS LP 02/14/2025 3.52 M $52.47 M   1.31% 3.86%
STATE STREET CORP 02/14/2025 2.99 M $44.58 M   -0.58% 3.28%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 2.00 M $29.72 M   -18.09% 2.18%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 1.70 M $25.35 M   11.70% 1.86%
SIREN, L.L.C. 02/14/2025 1.61 M $24.00 M   0.00% 1.76%
02/14/2025 1.60 M $23.86 M   100.00% 1.75%
AMERIPRISE FINANCIAL INC 02/14/2025 1.55 M $23.04 M   17.31% 1.69%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 02/12/2025 1.52 M $22.66 M   63.45% 1.67%
PARKMAN HEALTHCARE PARTNERS LLC 02/14/2025 1.27 M $18.97 M   24.18% 1.39%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 1.21 M $18.02 M   -1.03% 1.32%
MILLENNIUM MANAGEMENT LLC 02/14/2025 924.37 K $13.76 M   277.14% 1.01%
DECHENG CAPITAL LLC 02/14/2025 808.79 K $12.04 M   -7.01% 0.88%
BRAIDWELL LP 02/14/2025 802.10 K $11.94 M   100.00% 0.88%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 579.62 K $8.63 M   2.23% 0.63%
SUVRETTA CAPITAL MANAGEMENT, LLC 02/14/2025 576.16 K $8.58 M   -13.18% 0.63%
MORGAN STANLEY 02/14/2025 549.91 K $8.19 M   -23.03% 0.60%
NORTHERN TRUST CORP 02/14/2025 532.10 K $7.92 M   4.35% 0.58%
JACOBS LEVY EQUITY MANAGEMENT, INC 02/14/2025 465.30 K $6.93 M   100.00% 0.51%
GOLDMAN SACHS GROUP INC 02/11/2025 443.45 K $6.60 M   -36.95% 0.49%
ADAGE CAPITAL PARTNERS GP, L.L.C. 02/14/2025 443.00 K $6.60 M   100.00% 0.48%
BANK OF NEW YORK MELLON CORP 02/04/2025 381.62 K $5.68 M   8.62% 0.42%
MACQUARIE GROUP LTD 02/14/2025 379.10 K $5.65 M   0.00% 0.41%
IKARIAN CAPITAL, LLC 02/14/2025 378.36 K $5.63 M   -49.14% 0.41%
CITADEL ADVISORS LLC 02/14/2025 360.59 K $5.37 M   13.44% 0.39%
READYSTATE ASSET MANAGEMENT LP 02/14/2025 351.36 K $5.23 M   100.00% 0.38%
GRANAHAN INVESTMENT MANAGEMENT, LLC 02/14/2025 346.09 K $5.15 M   -3.28% 0.38%
TREXQUANT INVESTMENT LP 02/12/2025 300.55 K $4.48 M   241.55% 0.33%
PRINCIPAL FINANCIAL GROUP INC 01/31/2025 263.52 K $3.92 M   3.09% 0.29%
DAFNA CAPITAL MANAGEMENT LLC 02/14/2025 254.22 K $3.79 M   -0.97% 0.28%
AXA S.A. 02/14/2025 231.90 K $3.45 M   -0.16% 0.25%
CUBIST SYSTEMATIC STRATEGIES, LLC 02/14/2025 225.17 K $3.35 M   220.33% 0.25%
NORDEA INVESTMENT MANAGEMENT AB 01/06/2025 218.93 K $3.24 M   2.46% 0.24%
INVESCO LTD. 02/13/2025 203.99 K $3.04 M   21.36% 0.22%
JANE STREET GROUP, LLC 02/14/2025 202.50 K $3.02 M   -6.70% 0.22%
ALGERT GLOBAL LLC 02/14/2025 180.12 K $2.68 M   59.62% 0.20%
HUDSON BAY CAPITAL MANAGEMENT LP 02/14/2025 170.00 K $2.53 M   -2.86% 0.19%
02/14/2025 165.97 K $2.47 M   100.00% 0.18%
BANK OF AMERICA CORP /DE/ 02/14/2025 160.15 K $2.38 M   13.65% 0.18%
RHUMBLINE ADVISERS 01/30/2025 159.26 K $2.37 M   -1.59% 0.17%
PLATINUM INVESTMENT MANAGEMENT LTD 02/11/2025 153.78 K $2.29 M   0.00% 0.17%
LEGAL & GENERAL GROUP PLC 02/13/2025 149.21 K $2.22 M   1.52% 0.16%
TWO SIGMA INVESTMENTS, LP 02/14/2025 146.69 K $2.18 M   8.13% 0.16%
IKARIAN CAPITAL, LLC 02/14/2025 141.00 K $2.10 M   24.01% 0.15%
PUBLIC SECTOR PENSION INVESTMENT BOARD 02/14/2025 135.03 K $2.01 M   18.03% 0.15%
SCHONFELD STRATEGIC ADVISORS LLC 02/14/2025 135.00 K $2.01 M   -79.97% 0.15%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 131.86 K $1.96 M   -22.37% 0.14%

Arcus Biosciences, Inc. institutional Ownership - FAQ's

During the previous two years, 190 institutional investors and hedge funds held shares of Arcus Biosciences, Inc.. The most heavily invested institutionals were:

Asset Dedication, LLC: 0

Farther Finance Advisors, LLC: 0

SIGNATUREFD, LLC: 0

MASSMUTUAL TRUST CO FSB/ADV: 0

Ronald Blue Trust, Inc.: 0

GILEAD SCIENCES, INC.: 30.06 M

91.80% of Arcus Biosciences, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 86.27 M shares in the last 24 months. This purchase volume represents approximately $786.81 M in transactions.